The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant: Recipients: Results of the SCHEDULE Trial After 36 Months

被引：0

作者：

Arora, S. ^{[1
]}

Solberg, O. ^{[1
]}

Karason, K. ^{[2
]}

Andersson, B. ^{[2
]}

Gustafsson, F. ^{[3
]}

Eiskjaer, H. ^{[4
]}

Radegran, G. ^{[5
]}

Gude, E. ^{[1
]}

Ueland, T. ^{[6
]}

Aukrust, P. ^{[6
]}

Solbu, D. ^{[7
]}

Dellgren, G. ^{[2
]}

Andreassen, A. ^{[1
]}

Gullestad, L. ^{[1
]}

机构：

[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Cardiol, N-0027 Oslo, Norway

[2] Sahlgrens Univ Hosp, Cardiol, Gothenburg, Sweden

[3] Rigshosp, Cardiol, DK-2100 Copenhagen, Denmark

[4] Skejby Univ Hosp, Cardiol, Aarhus, Denmark

[5] Skane Univ Hosp, Cardiol, Lund, Sweden

[6] Univ Oslo, Rikshosp, Oslo Univ Hosp, Res Inst Internal Med, N-0027 Oslo, Norway

[7] Novartis Norge, Oslo, Norway

来源：

关键词：

D O I：

10.1016/j.healun.2015.01.225

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

212

引用

页码：S85 / S85

页数：1